Scarica l'app Stockscreener
196.04
1.82%
3.50
Dopo l'orario di chiusura:
197.33
1.29
+0.66%
Natera Inc Borsa (NTRA) Ultime notizie
Is It Time To Reassess Natera (NTRA) After The Recent Share Price Pullback - Yahoo Finance
Natera jumps after Signatera CDx wins FDA companion diagnostic approval in bladder cancer - Quiver Quantitative
NTRA's Signatera CDx Wins FDA Nod in Muscle-Invasive Bladder Cancer - The Globe and Mail
Natera wins FDA approval for companion diagnostic - MedTech Dive
5 Must-Read Analyst Questions From Natera’s Q1 Earnings Call - Yahoo Finance
What's Behind Natera CEO Steven Chapman's Recent Stock Sales? - Kavout
A Look At Natera (NTRA) Valuation After Recent Share Price Weakness - simplywall.st
Natera, Inc. (NTRA) Investor Outlook: Exploring A 39.99% Upside With Strong Buy Ratings - DirectorsTalk Interviews
Natera, Inc. CLASS ACTION Alert: Wolf Haldenstein Adler Freeman - GuruFocus
Natera Inc stock (US6323071042): insider selling and a sharp pullback unsettle investors - AD HOC NEWS
Natera Scores Rare FDA Approval but Shares Drop - TechStock²
Natera co-founder Sheena Jonathan sells $959,450 in company stock - Investing.com
Natera (NTRA) co-founder Jonathan Sheena sells 4,650 shares under 10b5-1 plans - Stock Titan
New blood test helps tailor bladder cancer treatment, wins FDA backing - Stock Titan
Roche's ctDNA-guided approach in post-surgical bladder cancer pays off with Tecentriq nod - Fierce Pharma
Natera's Signatera CDx Approved by FDA as Companion Diagnostic in Muscle-Invasive Bladder Cancer - Moomoo
Natera Gets FDA Approval for Bladder-Cancer Test - marketscreener.com
Signatera CDx Approved by the FDA as a Companion Diagnostic in Muscle-Invasive Bladder Cancer (MIBC) - Business Wire
NTRA Technical Analysis | Trend, Signals & Chart Patterns | NATERA INC (NASDAQ:NTRA) - ChartMill
Natera’s Stronghold in Cancer Recurrence Tests Prompts Wood’s Ark to Expand Stake - The Daily Upside
(NTRA) Movement as an Input in Quant Signal Sets - Stock Traders Daily
The Cancer Test That Wall Street Is Betting On - WSJ
Natera, Inc.Common Stock (NQ: NTRA - FinancialContent
Natera NTRA Q1 2026 Earnings Call Transcript - AOL.com
Natera (NTRA) Sees Recent Investment Surge from ARK Investment - GuruFocus
Cathie Wood’s ARK sells Twist Bioscience, buys Natera stock - Investing.com India
Cathie Wood’s ARK sells Twist Bioscience, buys Natera stock By Investing.com - Investing.com Australia
Analysts Have Made A Financial Statement On Natera, Inc.'s (NASDAQ:NTRA) First-Quarter Report - simplywall.st
Natera, Inc. (NASDAQ:NTRA) Just Released Its First-Quarter Earnings: Here's What Analysts Think - Moomoo
Why Natera (NTRA) Shares Are Plunging Today - Yahoo Finance
Natera price target raised to $249 from $240 at Piper Sandler - TipRanks
Why Natera (NTRA) Is Down 5.9% After Raising 2026 Guidance But Posting a Wider Q1 Loss - simplywall.st
NTRA Stock Price, Quote & Chart | NATERA INC (NASDAQ:NTRA) - ChartMill
NTRA Q1 Deep Dive: Robust Volume Growth and Product Expansion Shape Outlook - Yahoo Finance
Number of shareholders of Natera, Inc. – BX:NTRA - TradingView
Earnings call transcript: Natera Inc. sees mixed Q1 2026 results; stock drops By Investing.com - Investing.com Australia
NTRA Maintained by BTIG -- Price Target Lowered to $250 - GuruFocus
Earnings call transcript: Natera Inc. sees mixed Q1 2026 results; stock drops - Investing.com
Natera stock price target lowered to $250 by BTIG on valuation - Investing.com Nigeria
Assessing Natera (NTRA) Valuation After Recent Share Price Pullback And Long Term Returns - Yahoo Finance
Assessing Natera (NTRA) Valuation After Record Q1 Growth And Ongoing Profitability Concerns - simplywall.st
Natera (NTRA) Is Up 6.6% After Record Q1 Revenue But Wider LossesHas The Bull Case Changed? - Yahoo Finance
Natera Lifts 2026 Outlook As Test Volumes Climb And Japan Entry Nears - simplywall.st
Natera (NTRA) Q4 Profit Of US$47.3 Million Tests Longstanding Loss‑Making Narrative - Sahm
Natera Stock To $136? - Trefis
Natera Q1 2026 slides: revenue jumps 39%, guidance raised By Investing.com - Investing.com South Africa
Natera’s Earnings Call Signals Strong Growth Momentum - TipRanks
0.21%
1.37%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):